Drewinko B, Yang L Y
Cancer Treat Rep. 1985 Dec;69(12):1391-8.
Five established human colorectal carcinoma cell lines with distinct phenotypic properties were exposed to different concentrations of 5-FU for varying time intervals. Effects were measured by sequential cell counts and by inhibition of colony formation. Treatment for 1 hr with 1 microgram/ml barely decreased survival of all cell lines as measured by colony formation; at a concentration of 100 microgram/ml, survival was modestly reduced for all cell lines, and for concentrations of 1000 microgram/ml, survival was decreased by greater than 50%. Extending the length of the treatment interval markedly increased the degree of cell kill for all concentrations of 5-FU. Treatment for greater than 24 hrs resulted in almost complete extermination of colony-forming cells, even for relatively resistant cell lines. The effect of 5-FU treatment on cell number was more complex and depended on drug concentration, length of treatment, and type of cell line. In general, decrements in cell numbers were somewhat related to both drug concentration and length of treatment interval, especially if performed 7 days after terminating drug treatment. Earlier cell counts were inconclusive and the same result could be obtained for different drug concentrations or treatment intervals. Furthermore, these results would change on a daily basis. More important, cell count results never correlated with the survival endpoint measured by inhibition of colony formation. Our results suggest that enhancement of the currently poor performance of 5-FU in the treatment of human colon carcinoma could originate from changing the administration modality to long-term infusion.
将五种具有不同表型特征的成熟人结肠癌细胞系暴露于不同浓度的5-氟尿嘧啶(5-FU)中,持续不同的时间间隔。通过连续细胞计数和集落形成抑制来测量效果。用1微克/毫升处理1小时,通过集落形成测量,所有细胞系的存活率几乎没有降低;在100微克/毫升的浓度下,所有细胞系的存活率略有降低,而在1000微克/毫升的浓度下,存活率降低超过50%。延长处理间隔时间显著增加了所有浓度5-FU的细胞杀伤程度。处理超过24小时导致集落形成细胞几乎完全灭绝,即使对于相对耐药的细胞系也是如此。5-FU处理对细胞数量的影响更为复杂,取决于药物浓度、处理时间和细胞系类型。一般来说,细胞数量的减少在一定程度上与药物浓度和处理间隔时间有关,特别是在终止药物处理7天后进行计数时。早期的细胞计数结果不明确,不同药物浓度或处理间隔可能得到相同的结果。此外,这些结果每天都会变化。更重要的是,细胞计数结果与通过集落形成抑制测量的存活终点从未相关。我们的结果表明,改善5-FU目前在治疗人类结肠癌方面不佳的表现可能源于将给药方式改为长期输注。